Concomitant 5‐Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative Colitis

Documenti analoghi

• Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity
  di: Brigida Barberio, et al.
  Pubblicazione: (2026)
• Editorial: Effectiveness and safety of ustekinumab in ulcerative colitis—Where we are now in real life
  di: Giammarco Mocci, et al.
  Pubblicazione: (2024)
• Upper gastrointestinal Crohn's disease: What are we talking about?
  di: Luisa Bertin, et al.
  Pubblicazione: (2024)
• Effect of hiatal hernia and esophagogastric junction morphology on esophageal motility: Evidence from high‐resolution manometry studies
  di: Stefano Kayali, et al.
  Pubblicazione: (2024)
• Prospective Questionnaire Survey on Adherence to Oral 5‐Aminosalicylic Acid in Patients With Ulcerative Colitis
  di: Tsuyoshi Beppu, et al.
  Pubblicazione: (2025)